COVID-19 vaccination efforts accelerated
ECONOMY & POLICY

COVID-19 vaccination efforts accelerated

In a significant move to combat the ongoing COVID-19 pandemic, India has intensified its vaccination efforts, aiming to inoculate a larger portion of its population. As part of this initiative, the Government of India, through the Ministry of Health and Family Welfare, has announced various measures to expedite the vaccination process and ensure widespread coverage across the country.

With the emergence of new variants and the persistent threat posed by the virus, accelerating the vaccination drive has become imperative. The government's proactive approach aims to administer vaccines swiftly and efficiently to curb the spread of the virus and protect public health.

Through a series of strategic initiatives and collaborations with healthcare institutions and stakeholders, India is bolstering its vaccination infrastructure. This includes expanding vaccination centres, streamlining distribution channels, and leveraging technology to enhance the registration and scheduling process for vaccine appointments.

Furthermore, the government is actively engaging with vaccine manufacturers to ramp up production and ensure an uninterrupted supply of vaccines. Efforts are also underway to facilitate the procurement of additional doses to meet the growing demand and cover priority groups, including frontline workers, the elderly, and those with comorbidities.

In addition to accelerating the vaccination of its own citizens, India has also extended support to other nations by supplying COVID-19 vaccines through diplomatic channels and international collaborations. This gesture underscores India's commitment to global solidarity in the fight against the pandemic and reflects its role as a responsible global citizen.

Amidst the challenges posed by the pandemic, India remains steadfast in its commitment to safeguarding public health and mitigating the impact of COVID-19. The accelerated vaccination drive serves as a testament to the government's determination to overcome the crisis and build resilience against future health threats.

Through a combination of robust healthcare infrastructure, scientific innovation, and proactive measures, India is forging ahead in its battle against COVID-19. As the vaccination drive gains momentum, there is optimism that collective efforts will pave the way for a healthier and more resilient future for all.

In a significant move to combat the ongoing COVID-19 pandemic, India has intensified its vaccination efforts, aiming to inoculate a larger portion of its population. As part of this initiative, the Government of India, through the Ministry of Health and Family Welfare, has announced various measures to expedite the vaccination process and ensure widespread coverage across the country. With the emergence of new variants and the persistent threat posed by the virus, accelerating the vaccination drive has become imperative. The government's proactive approach aims to administer vaccines swiftly and efficiently to curb the spread of the virus and protect public health. Through a series of strategic initiatives and collaborations with healthcare institutions and stakeholders, India is bolstering its vaccination infrastructure. This includes expanding vaccination centres, streamlining distribution channels, and leveraging technology to enhance the registration and scheduling process for vaccine appointments. Furthermore, the government is actively engaging with vaccine manufacturers to ramp up production and ensure an uninterrupted supply of vaccines. Efforts are also underway to facilitate the procurement of additional doses to meet the growing demand and cover priority groups, including frontline workers, the elderly, and those with comorbidities. In addition to accelerating the vaccination of its own citizens, India has also extended support to other nations by supplying COVID-19 vaccines through diplomatic channels and international collaborations. This gesture underscores India's commitment to global solidarity in the fight against the pandemic and reflects its role as a responsible global citizen. Amidst the challenges posed by the pandemic, India remains steadfast in its commitment to safeguarding public health and mitigating the impact of COVID-19. The accelerated vaccination drive serves as a testament to the government's determination to overcome the crisis and build resilience against future health threats. Through a combination of robust healthcare infrastructure, scientific innovation, and proactive measures, India is forging ahead in its battle against COVID-19. As the vaccination drive gains momentum, there is optimism that collective efforts will pave the way for a healthier and more resilient future for all.

Related Stories

Gold Stories

Next Story
Infrastructure Energy

Asian Energy Services Q1 FY27 PAT Rises 129 Per Cent

Asian Energy Services Limited reported a 129 per cent year-on-year rise in net profit to Rs 128 million for Q1 FY27, compared with the corresponding quarter last year.Revenue increased 135 per cent year-on-year to Rs 2.71 billion, supported by continued momentum across its services business, disciplined execution and contributions from domestic and international operations. EBITDA grew 81 per cent year-on-year during the quarter.As of June 30, 2026, the company’s standalone order book stood at Rs 17.54 billion, with around 60 per cent coming from oil and gas services and 40 per cent from min..

Next Story
Infrastructure Urban

BioBTX to Build First Commercial-Scale Circular Chemicals Plant

Dutch circular chemistry technology developer BioBTX is building what it says will be the world’s first commercial-scale plant to convert mixed plastic waste into high-quality aromatic chemicals using its proprietary Integrated Catalytic Cracking Process (ICCP) technology.The facility will be built at Chemical Park Delfzijl on the northern coast of the Netherlands and is expected to create 35 jobs. Covestro, which has been a shareholder and strategic partner of BioBTX since 2024, holds a mid-single-digit million-euro investment in the company.BioBTX’s ICCP technology uses catalytic pyrolys..

Next Story
Real Estate

Awfis Q1 FY27 PAT Jumps 140% as Revenue Rises 27%

Awfis Space Solutions reported a 140 per cent year-on-year rise in consolidated profit after tax (PAT) to Rs 240 million for Q1 FY27, compared with Rs 100 million in the corresponding quarter last year.Revenue from operations increased 27 per cent to Rs 4.25 billion from Rs 3.35 billion, while EBITDA rose 28 per cent to Rs 1.62 billion. EBITDA margin improved to 38.2 per cent from 37.8 per cent. Profit before tax increased 135 per cent to Rs 240 million.The company's co-working business recorded 27 per cent year-on-year growth, supported by demand from enterprises, Global Capability Centres (G..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement